Cameroon

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Cameroon is regulated by the LANACOME (Laboratoire National de Contrôle de Médicaments). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

LANACOME (Laboratoire National de Contrôle de Médicaments)

Regulatory Pathways (1)

Cameroon MOH Autorisation Exceptionnelle 30 days

Cameroon Ministry of Health exceptional authorization for import of unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Cameroon Exceptional Authorization Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Cameroon

ISO Code	`CM`
Region	Africa
Regulatory Authority	LANACOME (Laboratoire National de Contrôle de Médicaments)
Pathways	1 documented
Drugs Available	0 documented